Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blocking IL-1 in systemic inflammation.

Charles A Dinarello1

  • 1Division of Infectious Diseases, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. cdinare333@aol.com

The Journal of Experimental Medicine
|May 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OLT1177 (Dapansutrile) inhibits Gasdermin D-dependent IL-1β Release and Pyroptotic Cell Death in Bone Marrow-derived Macrophages.

bioRxiv : the preprint server for biology·2026
Same author

Reduced CCL/Be-specific CD4+ T cells in CCL3-deficient or peptide-MHC II CAR-T cell-treated mice.

JCI insight·2026
Same author

Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism.

Journal of neuroinflammation·2026
Same author

Human Alpha-1 Antitrypsin Suppresses Melanoma Growth by Promoting Tumor Differentiation and CD8<sup>+</sup> T-Cell-Mediated Immunity.

Biomolecules·2026
Same author

A Functional Polymorphism in IL-36β Modulates Macrophage Antifungal Effector Functions and Increases Susceptibility to Invasive Pulmonary Aspergillosis.

The Journal of infectious diseases·2025
Same author

Inflammation Promotes Aging-Associated Oncogenesis in the Lung.

Aging and cancer·2025
Same journal

Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.

The Journal of experimental medicine·2026
Same journal

Intravesical mesothelin-based CAR T cells targeting MUC16 effectively control bladder cancer in preclinical models.

The Journal of experimental medicine·2026
Same journal

Flawed translation triggers oncogenic B-T cell communication.

The Journal of experimental medicine·2026
Same journal

Correction: LCK'ed in: Inborn errors of immunity in LCK reveal how TCR signaling is calibrated.

The Journal of experimental medicine·2026
Same journal

Mechanobiology of inflammation: Pulling the strings of innate immunity.

The Journal of experimental medicine·2026
Same journal

Bile acid retention in efferocytic macrophages shapes their inflammatory status during cholangitis.

The Journal of experimental medicine·2026
See all related articles

Interleukin-1 (IL-1) activity drives systemic inflammatory diseases, including systemic onset juvenile idiopathic arthritis (SoJIA). Blocking IL-1 receptors rapidly resolves inflammation, suggesting IL-1beta dysregulation is a common disease mechanism.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Medicine

Background:

  • Systemic inflammatory diseases share symptoms like fevers, leukocytosis, anemia, and elevated acute phase proteins.
  • These diseases are increasingly linked to interleukin-1 (IL-1) pathway overactivity.
  • Specific blockade of IL-1 receptors leads to rapid and sustained disease resolution.

Purpose of the Study:

  • To investigate the role of IL-1 activity in systemic inflammatory diseases.
  • To explore the potential mechanism of IL-1beta dysregulation in these conditions.
  • To highlight the therapeutic implications of IL-1 blockade in systemic onset juvenile idiopathic arthritis (SoJIA).

Main Methods:

  • Review of existing literature on systemic inflammatory diseases and IL-1.

Related Experiment Videos

  • Analysis of clinical observations linking IL-1 receptor blockade to disease resolution.
  • Hypothesis generation regarding IL-1beta secretion control in disease pathogenesis.

    • Main Results:

    • Rapid and sustained resolution of inflammation is observed with IL-1 receptor blockade in various systemic inflammatory diseases.
    • Similar rapid resolution of both systemic and local inflammation is now reported in SoJIA.
    • Evidence suggests a common underlying mechanism involving aberrant IL-1 activity.

    Conclusions:

    • Interleukin-1 (IL-1) plays a critical role in the pathogenesis of systemic inflammatory diseases.
    • Loss of control over IL-1beta secretion may be a shared mechanism driving these conditions.
    • Targeting the IL-1 pathway offers a promising therapeutic strategy for diseases like SoJIA.